Skip to content

GHRP-2: Side Effects & Safety

Part of the GHRP-2 Complete Guide

Partner

Research Peptides

BioLongevity Labs15% Off
Shop Peptides at BioLongevity Labs

We may earn a commission if you purchase through this link, at no extra cost to you.

Overall Safety Profile

GHRP-2 is less selective than ipamorelin, producing notable cortisol and prolactin elevations alongside GH release. These off-target hormonal effects are the primary trade-off for its superior GH-releasing potency. Approved as a diagnostic agent in Japan, providing some safety validation for acute use.

Reported Side Effects

  • Cortisol elevation: Clinically significant — may counteract anabolic benefits with chronic use
  • Prolactin elevation: Can affect reproductive function, libido, and mood
  • Appetite increase: Moderate hunger stimulation (less than GHRP-6)
  • Water retention: GH-mediated
  • Flushing and tingling: Common immediately after injection

Important Limitations

Chronic cortisol elevation promotes visceral fat storage, muscle catabolism, and immune suppression — partially counteracting the intended anabolic effects. Prolactin elevation can cause gynecomastia, reduced libido, and mood changes. Long-term safety data from research use is absent.

Potential Contraindications

  • Hyperprolactinemia or prolactin-sensitive conditions
  • Cushing's syndrome or cortisol-related conditions
  • Active cancer
  • Pregnancy and breastfeeding

Researching peptides? We did the hard part.

Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.

Related Guides

PI

Peptides Insider Editorial Team

Our content is reviewed for accuracy and grounded in peer-reviewed research where available. We do not provide medical advice. Always consult a qualified healthcare professional.